Compare

Shattuck Labs, Inc. vs 60 Degrees Pharmaceuticals, Inc. vs Dare Bioscience, Inc. vs Rafael Holdings, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearShattuck Labs, Inc.
STTK
60 Degrees Pharmaceuticals, Inc.
SXTP
Dare Bioscience, Inc.
DARE
Rafael Holdings, Inc.
RFL
Year ended2025-12-312025-12-312025-12-312026-07-31
Revenue$1.00M$1.01M$1.03M$874.0K
Revenue growth (YoY)-82.5%+65.5%n/m-4.7%
Gross marginn/a22.3%71.3% (computed)n/a
Operating marginn/m-771.6%n/mn/m
Net marginn/m-732.5%n/mn/m
Net income-$48.81M-$7.37M-$13.40M-$29.64M
EPS (Diluted)-$0.70-$11.73-$1.20-$0.58
Operating cash flow-$39.88M-$6.85M-$9.90M-$29.99M
Free cash flow-$39.95M-$6.99M-$10.29M-$29.99M
Cash & equivalents$54.19M$1.51M$24.71M$22.10M
Total assets$91.03M$5.37M$32.47M$83.06M
Total liabilities$8.64M$1.99M$29.63M$11.09M
Shareholders' equity$82.39M$3.46M$2.84M$71.97M
Return on year-end equity-59.2%-212.7%-471.4%-41.2%
Shares outstanding63.28M1.16M14.50Mn/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearShattuck Labs, Inc.60 Degrees Pharmaceuticals, Inc.Dare Bioscience, Inc.Rafael Holdings, Inc.
Latest$1.00M
Ended 2025-12-31
$1.01M
Ended 2025-12-31
$1.03M
Ended 2025-12-31
$874.0K
Ended 2026-07-31
1 year earlier$5.72M
Ended 2024-12-31
$607.6K
Ended 2024-12-31
$9.8K
Ended 2024-12-31
$917.0K
Ended 2025-07-31
2 years earlier$1.66M
Ended 2023-12-31
$253.6K
Ended 2023-12-31
$2.81M
Ended 2023-12-31
$637.0K
Ended 2024-07-31
3 years earlier$652.0K
Ended 2022-12-31
$223.2K
Ended 2022-12-31
$10.00M
Ended 2022-12-31
$279.0K
Ended 2023-07-31
4 years earlier$30.02M
Ended 2021-12-31
n/a$0
Ended 2021-12-31
$410.0K
Ended 2022-07-31